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Abstract
Background: Uncontrolled inflammation participates in the development of inflammatory diseases. Beneficial
effects of polyunsaturated fatty acids belonging to the n-3 family such as eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA) on inflammation have been reported.
The present study investigates the basal effects of EPA, DHA and a mixture EPA + DHA on the expression of 10
genes (AKT1, MAPK, NFKB, TNFA, IL1Β, MCP1, ALOX5, PTGS2, MGST1and NOS2) related to inflammation in unstimulated
cultured THP1 macrophages. Cells were incubated for 24 h with n-3 PUFAs (50 μM and 10 μM EPA, DHA, EPA +
DHA). Expression levels of inflammatory genes were analyzed by real-time PCR.
Results: 50 μM, 10 μM EPA and 50 μM EPA + DHA decreased the expression of genes involved in the
NF-κB pathway (MAPK, AKT1, and NFKB). Treatment with 50 μM, 10 μM EPA, 50 μM DHA and EPA + DHA decreased
expression levels of cytokines genes IL1Β and MCP1. TNFA expression was decreased by 50 μM, 10 μM of EPA, DHA
and with 50 μM EPA + DHA. Two genes involved in the fatty acid metabolism (PTGS2 and ALOX5) were also
modulated by the n-3 FAs. 50 μM of DHA and EPA + DHA inhibited PTGS2 expression when the two concentrations
of EPA, 50 μM DHA and EPA + DHA inhibited ALOX5 expression. Finally, the effects of n-3 FAs were studied among
genes involved in the oxidative stress. 50 μM of each fatty acid increased MGST1 expression. Both concentration of
EPA and 50 μM DHA decreased NOS2 expression.
Conclusion: EPA seems to be more effective than DHA and EPA + DHA in modulating expression levels of selected
inflammatory genes. The concentration of 50 μM was globally more effective than 10 μM.
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Background
Inflammation is part of the body’s immediate response to
injury. It starts the immunologic elimination of invading
pathogens and toxins in order to repair damaged tissues.
During this stage, immune cells produce inflammatory
molecules participating in the destruction of foreign agents
[6, 31]. Although inflammation is a normal response, it can
harm host tissues when uncontrolled. Such inappropriate
inflammatory responses are in part characterized by an
abnormal production of inflammatory mediators by
peripheral blood mononuclear cells (PBMCs) triggering in-
flammatory diseases [8, 20, 32].
Polyunsaturated fatty acids (PUFAs) are natural con-
stituents of the diet, having a wide spectrum of physio-
logical roles [5, 8, 28]. Omega-6 (n-6) and omega-3 (n-3)
fatty acids (FAs) are two classes of PUFAs. Linoleic acid
(n-6 fatty acids) and alpha linolenic acid ((ALA) n-3
FAs) are essential FAs. They cannot be synthetized by
the body and must be provided through the diet. The
major end product of n-6 FAs is arachidonic acid (AA).
AA generally leads to the production of pro-inflammatory
eicosanoids. ALA is the precursor of eicosapentaenoic
(EPA, 20:5n-3) and docosahexaenoic (DHA, 22:6n-3) acids
producing anti-inflammatory eicosanoids involved in the
resolution of inflammation [4, 29]. Unfortunately, cellular
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mechanisms by which n-3 FAs act on immune cells are
not completely understood.
In vitro studies revealed that both EPA and DHA may
influence the functional responses of immune cells to
stimulation by reducing the production of pro-
inflammatory mediators. Early studies in experimental
models of autoimmunity [15] and clinical trials on fish
oil in patients with rheumatoid arthritis [13] demon-
strated significant anti-inflammatory activity of the com-
bination of EPA and DHA. The beneficial effects of n-3
FAs are thought to result from their anti-inflammatory
effects, in part through changes in gene expression
levels. In women with type 2 diabetes and without
hypertiglyceridemia Kabir et al. showed that expression
levels of inflammation-related genes were reduced in
adipose tissue after n-3 FA supplementation [10]. In the
same manner, a transcriptomic study in elderly subjects
by Bowens et al. showed that a supplementation with 1.8 g
of EPA+DHA per day could alter gene expression toward
a more anti-inflammatory profile among participants with-
out inflammatory disease [3]. Finally, our team demon-
strated that n-3 FAs supplementation (1.9 g EPA+ 1.1 g
DHA/day during 6 weeks) in healthy men and women
could alter gene expression levels of inflammation-related
genes [24]. A decrease of the expression of TNFA (37 %)
and MGST1 (17 %) was seen following this supplementa-
tion, reinforcing the notion that EPA and DHA have an
anti-inflammatory effect. This study also showed an alter-
ation of pathways biologically related to inflammation and
influenced by n-3 FAs supplementation. In fact, NFKB and
oxidative stress signalling pathways were modulated after
this supplementation [24].
It is important to further understand the molecular
mechanisms underlying beneficial effects of PUFAs, such
as EPA and DHA, in non-inflamed human immune cells.
Therefore, the aim of this study was to investigate the ef-
fect of EPA, DHA and a mixture of EPA and DHA on
expression levels of genes involved in inflammation in
THP-1 macrophages were the inflammation was not in-
duced. This study was realized on THP-1 macrophages
because of the similarity of their transcriptomic profile
with human primary cells [22].
Methods
Reagents and cell lines
Phosphate-buffered saline (PBS) solution was obtained
from Life Technologies (Burlington, Canada). Cell cul-
ture media, Roswell Park Memorial Institute medium
1640 (RPMI), Fetal Bovine Serum (FBS), penicillin and
streptomycin media supplements, phorbol 12-myristate
13-acetate (PMA), dimethyl sulfoxide (DMSO) were pur-
chased from Thermo Scientific (Walthman, USA). EPA,
DHA and reagents for reverse transcription were ob-
tained from Applied biosystems (Oakville, Canada).
Cell culture and Fatty acids treatment
The human THP-1 cell line, an acute monocytic
leukemia cell line (American Type Culture Collection
(ATCC), Rockville, MD, USA), was cultured in RPMI-
1640 media supplemented with 10 % FBS, penicillin (100
U/ml) and streptomycin (100 μM/ml) at 37 °C in a 5 %
CO2 incubator. To induce differentiation of monocytes
into macrophages, 106 cells per ml were seeded into 12
well plates, with 200 nM of PMA for 72 h. After incuba-
tion, non-attached cells were removed by aspiration, and
the adherent cells were washed with PBS three times.
Preliminary tests were done to determine the optimum
conditions for this study which were an incubation of
24 h in 50 and 10 μM of n-3 FAs. Stock solutions of FAs
(EPA-DMSO 330 nM and DHA-DMSO 760nM) pre-
pared in serum-free RPMI 1640 medium were diluted in
culture medium to obtain 50 and 10 μM concentrations.
Cells were thereafter incubated in 50 and 10 μM of EPA,
DHA and in 50 μM (25 μM EPA + 25 μM DHA) or
10 μM (5 μM EPA + 5 μM DHA) EPA +DHA for 24 h.
The controls in this experiment were THP-1 cells incu-
bated with the vehicle, DMSO.
RNA isolation and quantitative real-time PCR
After 24 h, total RNA was extracted using RNeasy Mini
Kit (Qiagen) following the protocol provided. Then
cDNA was produced from RNA using High Capacity
Transcription Kit (Applied biosystems). Real-time PCR
was used to determine the expression of several inflam-
matory genes (Table 1) related to FA metabolism, FA re-
ceptors, oxidative stress, NF-κB signalling or toll-like
receptor signaling. PCR samples were normalized against
18S gene expression. Primers and TaqMan® probes were
obtained from Applied Biosystems (Table 1). Finally,
each experimental treatment was performed three times
and replicates were analyzed.
Statistical analyses
Gene expression levels were analyzed using SAS soft-
ware (version 9.12). Experimental results are reported as
means ± S.E. from at least three independent experi-
ences performed each in triplicate. Treatments were
compared to control and to different concentrations
using the least square means. The level of significance
was defined as P < 0.05 for all tests.
Results
Effects of n-3 FAs on cytokine gene expression
EPA significantly reduced the expression of genes coding
for cytokines IL1B, MCP1 and TNFA, Fig. 1. EPA con-
centrations of 10 and 50 μM equally reduced the expres-
sion of MCP1 and IL1B. As far as TNFA was concerned
50 μM of omega-3 FA reduced its expression more ef-
fectively than 10 μM. When cells were incubated with
Allam-Ndoul et al. Lipids in Health and Disease  (2016) 15:69 Page 2 of 7
50 μM of DHA, the down-regulation of TNFA and IL1B
was more intense than with10 μM. The expression of
MCP1 was equally decreased with 50 or 10 μM of both
EPA and DHA. The mixture EPA +DHA down regulated
the expression of MCP1, TNFA and IL1B but only with
the concentration of 50 μM while 10 μM of EPA +DHA
did not affect their expression. Except for TNFA on which
EPA and DHA had the same effect; EPA seemed to have a
more powerful action on the expression of MCP1 and
IL1B than DHA and EPA +DHA.
Effects of n-3 FAs on the expression of genes involved in FA
The effect of EPA, DHA and EPA +DHA on the expres-
sion of two genes involved in the FA metabolism
(ALOX5 and PTGS2) is presented in Fig. 2. Relative to
vehicle control-related cells, 10 and 50 μM of EPA
equally decreased the expression of ALOX5. DHA and
EPA + DHA also decreased its expression, but only
when the concentration of 50 μM was used. The expres-
sion of PTGS2 was also modulated by the omega-3 FAs.
A treatment of THP-1 cells with 50 μM of DHA and
EPA + DHA reduced its expression when EPA did not
have any effect on PTGS2 gene expression levels.
Effects of n-3 FAs on NF-κB pathway gene expression
Figure 3 shows the effect of EPA, DHA and EPA +DHA
on three genes (AKT1, MAPK and NFKB) involved in
the NFKB pathway. 50 and 10 μM of EPA equally inhib-
ited the expression of each of these genes. No significant
changes in the expression of NFKB, MAPK and AKT1
were seen when cells were incubated in DHA. The mix-
ture EPA + DHA at a concentration of 50 μM decreased
the expression of NFKB and AKT1 but had no effect on
MAPK. The concentration of 10 μM did not change the
expression of these 3 genes. EPA seemed to be more ef-
fective on inhibiting NFKB, MAPK and AKT1 than
DHA or the mixture EPA +DHA.
Effects of n-3 FAs on the expression of oxidative stress
genes
Finally, we studied changes in the expression of two
genes involved in the oxidative stress (MGST1 and
NOS2-Fig. 4). At a concentration of 50 μM EPA and
DHA up-regulated the expression of MGST1 whereas
10 μM did not have any effect. For NOS2, 50 μM of EPA
and DHA decreased its expression more efficiently than
10 μM. The mixture EPA +DHA did not have any effect
on the expression of these genes. EPA had a more
powerful effect on the expression of MGST1 and NOS2
than DHA or the mixture EPA +DHA.
Discussion
Inflammation is a condition which contributes to a range
of human diseases [7, 27]. EPA and DHA are the major
n-3 FAs found in oily fish and fish oil supplements.
There is substantial evidence that these FAs are able to
partly inhibit several aspects of inflammation, including
production of inflammatory cells [27] and eicosanoids
from n-6 [31]. The literature had shown that the influ-
ence of EPA and DHA on immune cell functions is me-
diated by several mechanisms [4]. In this study, we
focused on the action of EPA and DHA on the regula-
tion of inflammatory gene expression levels on unstimu-
lated THP-1 cells. Literature showed that an increased
intake of EPA and DHA resulted in an increased
Table 1 Genes and primers sets for real-time PCR
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incorporation of n-3 FAs in membrane phospholipids of
immune cells [6]. N-3 FAs can then modulate the ex-
pression of several inflammatory genes by interacting
with various nuclear receptor and transcription factors
[4]. NFKB is a key transcription factor involved in the
up-regulation of cyclooxygenase (COX2) gene, adhesion
molecules and inflammatory cytokines [14, 26]. Previous
studies reported that fish oil decrease LPS-induced acti-
vation of NFKB in human monocytes [17, 32]. Singer et
al., suggested that EPA and DHA could inhibit NFKB ac-
tivity at several levels during NF-κB pathway [32]. Fol-
lowing this lead, we studied in unstimulated
macrophages, the expression levels of genes involved in
this pathway. We demonstrate that EPA and EPA +
DHA, but not DHA, slightly depressed the expression of
genes involved in NF-κB pathway (AKT1, MAPK and
NFKB). The modulation of these genes expression being
very low, we can hypothesise that in unstimulated mac-
rophages the action of EPA and DHA does not seem to
go through NF-κB pathway alone. Other mechanisms
might be involved.
In addition, EPA suppressed the mRNA expression of
pro-inflammatory cytokines (IL1B, MCP1 and TNFA) in
THP-1 monocyte-derived macrophages. As mentioned
previously, in inflammatory conditions, NFKB plays key
roles in up-regulating pro-inflammatory cytokine gene
transcription [9]. The results of this study suggest that
the effects observed on cytokines can reflect upstream
actions on genes from the NF-κB pathway. Effects on
gene expression being relatively modest, we can also hy-
pothesise that n-3 FAs may act on expression levels of
cytokine genes by other mechanisms.
Fig. 1 Effects of n-3 FAs on cytokine gene expression after a 24 h incubation of THP-1 macrophages in 10 μM and 50 μM of EPA, DHA and EPA +DHA.
a,b Represents the differences (P≤ 0.05) between the 2 concentrations for each omega-3 FAs and for the mixture EPA +DHA. *P≤ 0.05 relative to DMSO;
1P ≤0.05 relative to EPA within the same concentration; 2P≤ 0.05 relative to DHA within the same concentration
Fig. 2 Effects of n-3 FAs on the expression of genes involved in FA metabolism. a,b Represents the differences (P≤ 0.05) between the 2 concentrations
for each omega-3 FAs and for the mixture EPA + DHA. *P≤ 0.05 relative to DMSO; 1P ≤0.05 relative to EPA within the same concentration; 2P≤ 0.05
relative to DHA within the same concentration
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It is important to highlight the fact that the aim of the
present study was to investigate the effect of EPA, DHA
and EPA +DHA on the expression of inflammatory
genes, in cells under baseline inflammatory conditions.
Studies investigating the effects of n-3 FAs on inflamma-
tion without induction of inflammation are limited. In
most in vitro studies, induction of inflammation with
different chemicals (LPS, TNFA, and interferon gamma)
is triggered to evaluate the effects of n-3 FAs [19].
Changes in gene expression levels are thus more import-
ant in these models. It might be a reason why the effects
of n-3 FAs are not as pronounced here as in studies with
induced inflammation. In vitro and clinical [2] studies
showed that EPA, DHA and fish oil supplements can de-
crease production of pro-inflammatory cytokines. In
addition, a study by Wang and coll., on macrophages
treated with EPA and DHA showed reduced expression of
TNFA, IL6 and MCP1 compared to controls [30]. These
results highlight the ability of EPA, DHA and EPA +DHA
to down-regulate pro-inflammatory markers, even in the
absence of pro-inflammatory stimuli thus suggesting a
protective effect of n-3 FAs on THP-1 macrophages in-
flammatory profile concordant with reported health bene-
fits (7). Combined with data from the present study, these
findings suggest that the inverse relationship between n-3
FAs and inflammation may be partly due to their ability to
modulate macrophage cytokine secretion via NF-κB
pathway.
Eicosanoids are biologically active lipid mediators pro-
duced from PUFA, mainly AA. They are important media-
tors of inflammation [16]. The prostaglandin-endoperoxide
synthase (PTGS; also called cyclooxygenase (COX)) and
Fig. 3 Effects of omega-3 FAs on the expression of genes involved in NF-κB pathway. a,b Represents the differences (P ≤ 0.05) between the 2
concentrations for each omega-3 FAs and for the mixture EPA + DHA. *P ≤ 0.05 relative to DMSO; 1P ≤0.05 relative to EPA within the same
concentration; 2P ≤ 0.05 relative to DHA within the same concentration
Fig. 4 Effects of n-3 FAs on the expression of genes involved in oxidative stress. a,b Represents the differences (P≤ 0.05) between the 2 concentrations
for each omega-3 FAs and for the mixture EPA + DHA. *P≤ 0.05 relative to DMSO; 1P ≤0.05 relative to EPA within the same concentration; 2P≤ 0.05
relative to DHA within the same concentration
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the lipoxygenase (ALOX) are two enzymes contributing to
the synthesis of eicosanoids. AA is abundant in membrane
phospholipids. It produces pro-inflammatory eicosanoids
through these enzymes [5]. EPA and DHA are weaker sub-
strates for ALOX5 and PTGS2 than AA. They produce less
potent eicosanoids and lipid mediators (resolvins, maresins,
protectins), with an anti-inflammatory profile. The present
study shows a dose and n-3 FAs dependent reduction of
the expression of ALOX5 and PTGS2 when cells are ex-
posed to these FAs. As shown in the literature, the incorp-
oration of EPA and DHA into inflammatory cells occurs at
the expense of AA [6]. This might explain the decrease in
gene expression levels of PTGS2 and ALOX5.
We also studied the effect of n-3 FAs on the expression
of genes involved in oxidative stress. Reactive oxygen spe-
cies (ROS) are produced by the body and are important in
normal cellular functioning. Neutralising ectopic oxidative
stress is very important to maintain the body’s integrity.
The potential role of oxidative stress as an early event in
inflammatory diseases has been widely noted [23]. To
prevent abnormal oxidative stress, several physiological
anti-oxidant systems act as protective mechanisms.
Microsomal glutathione S- transferase 1 (MGST1) and
heme oxygenase (HO-1) are enzymes which detoxify re-
active intermediates. Nitric Oxide Synthase (NOS) cata-
lyzes the production of nitric oxide (NO), a free radical, as
a defense mechanism. During pathological inflammation
NO is produced in an excessive manner leading to cell
damages. Figure 4 suggests that even when inflammation
is not induced, n-3 FAs act on oxidative stress by reducing
the expression of a pro-oxidative gene (NOS2) and en-
hancing the expression of MGST1, an anti-oxidative
gene. In the previous study led by our laboratory [24],
the 30 participants had a body mass index between 25
and 40 kg/m2. It means that they were overweight to
obese participants. Thus the results of this study were
from individuals with a potential chronic inflammatory
state whereas our in vitro study was performed on un-
stimulated macrophages. In the clinical trial, each par-
ticipant received 5 capsules containing 1 g oil each per
day (1.9 g EPA and 1.1 g DHA). It is of note that the re-
sponses observed in this human clinical study may be
modulated by genetic variations that influenced the in-
dividual response to n-3 FAs supplementation. These
facts might be partly explaining the difference regarding
MGST1 expression between the human and the in vitro
studies. It is also important to consider the fact that the
in vitro study considerably simplifies what is observed
in the human body. In fact it doesn’t really take into ac-
count different interactions that can be observed in the
human body. The role of n-3 FAs on the restoration of
free radical homeostasis is not fully understood al-
though studies suggest that EPA and DHA reduce oxi-
dative damages in human and animals [1, 18].
N-3 FAs have beneficial effects on inflammation [4]. It
is important to know whether effects of each o n-3 FAs
on inflammation are similar. This study shows that in
unstimulated macrophages, depending on the metabolic
pathway of interest, the n-3 FA having the most import-
ant effect is different. Globally, EPA has the most potent
effect on gene expression comparatively to DHA and
EPA +DHA. Interestingly, in most studies on the effect
of EPA and DHA on inflammatory genes, DHA was a
more potent inhibitor of inflammatory genes than EPA
[11, 12, 19, 21]. However, inflammation was induced in
these studies while in the present study effects of n-3 FAs
on macrophages were studied without induced inflamma-
tion. The greater effect of DHA seems to come from its
secretion of more anti-inflammatory lipid mediators
(Resolvin D, maresins, protectins) than EPA (Resolvin E)
[6, 25]. It could explain that in studies where inflammation
is induced, the effects of DHA on expression levels of in-
flammatory genes were more intense than EPA. Indeed,
the induction of inflammation triggers the synthesis of
resolvins and other lipid mediators derived from n-3 FAs
not seen in cells when inflammation is not induced.
Stimulation of a macrophage cell culture with an inflam-
matory agent may lead to different results but this need to
be confirmed.
A dose effect of the omega-3 FA is also seen. Globally
incubating the cells with 50 μM of each omega-3 FAs
seems to be more efficient then with 10 μM. Thus, when
studying the effects of omega-3 FAs, the concentrations
must be carefully set in order to truly observe their action.
Conclusion
N-3 FAs may modulate the expression of genes related
to inflammation. In fact these FAs seem to down-
regulate the expression of genes promoting inflamma-
tion (cytokines, NF-κB pathway) and up-regulate the ex-
pression of MGST1 involved in the prevention of
inflammation through detoxification of ROS. The n-3
FAs used in this study have distinct effects on gene ex-
pression, EPA having a more potent effect than DHA
and or EPA +DHA combined. A dose effect was also
seen, in fact higher concentrations (50 μM) being more
potent than lower ones (10 μM).
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